O'Donnell K - Search Results

1

Quantitation of cytomegalovirus in the blood of liver transplant recipients.

Mutimer D, Matyi-Toth A, Elias E, Shaw J, O'Donnell K, Kilgariff H, Neuberger J, Gunson B, McMaster P, Stalhandske P. Mutimer D, et al. Liver Transpl Surg. 1995 Nov;1(6):395-400. doi: 10.1002/lt.500010611. Liver Transpl Surg. 1995. PMID: 9346619 Free article.

2

Patterns of viremia in liver transplant recipients with symptomatic cytomegalovirus infection.

Mutimer D, Matyi-Toth A, Shaw J, Elias E, O'Donnell K, Stalhandske P. Mutimer D, et al. Transplantation. 1997 Jan 15;63(1):68-73. doi: 10.1097/00007890-199701150-00013. Transplantation. 1997. PMID: 9000663

3

Enhanced (cytomegalovirus) viral replication associated with septic bacterial complications in liver transplant recipients.

Mutimer D, Mirza D, Shaw J, O'Donnell K, Elias E. Mutimer D, et al. Transplantation. 1997 May 27;63(10):1411-5. doi: 10.1097/00007890-199705270-00007. Transplantation. 1997. PMID: 9175802

4

Enhanced (cytomegalovirus) viral replication after transplantation for fulminant hepatic failure.

Mutimer DJ, Shaw J, O'Donnell K, Elias E. Mutimer DJ, et al. Liver Transpl Surg. 1997 Sep;3(5):506-12. doi: 10.1002/lt.500030505. Liver Transpl Surg. 1997. PMID: 9346793 Free article.

5

Outcome of lamivudine resistant hepatitis B virus infection in the liver transplant recipient.

Mutimer D, Pillay D, Shields P, Cane P, Ratcliffe D, Martin B, Buchan S, Boxall L, O'Donnell K, Shaw J, Hübscher S, Elias E. Mutimer D, et al. Gut. 2000 Jan;46(1):107-13. doi: 10.1136/gut.46.1.107. Gut. 2000. PMID: 10601065 Free PMC article.

6

High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation.

Mutimer D, Pillay D, Dragon E, Tang H, Ahmed M, O'Donnell K, Shaw J, Burroughs N, Rand D, Cane P, Martin B, Buchan S, Boxall E, Barmat S, Gutekunst K, McMaster P, Elias E. Mutimer D, et al. J Hepatol. 1999 Apr;30(4):715-21. doi: 10.1016/s0168-8278(99)80204-9. J Hepatol. 1999. PMID: 10207815 Clinical Trial.

7

Selection of hepatitis B surface "escape" mutants during passive immune prophylaxis following liver transplantation: potential impact of genetic changes on polymerase protein function.

Shields PL, Owsianka A, Carman WF, Boxall E, Hubscher SG, Shaw J, O'Donnell K, Elias E, Mutimer DJ. Shields PL, et al. Gut. 1999 Aug;45(2):306-9. doi: 10.1136/gut.45.2.306. Gut. 1999. PMID: 10403747 Free PMC article.

8

Selection of multiresistant hepatitis B virus during sequential nucleoside-analogue therapy.

Mutimer D, Pillay D, Cook P, Ratcliffe D, O'Donnell K, Dowling D, Shaw J, Elias E, Cane PA. Mutimer D, et al. J Infect Dis. 2000 Feb;181(2):713-6. doi: 10.1086/315238. J Infect Dis. 2000. PMID: 10669360

9

Additive antiviral effects of lamivudine and alpha-interferon in chronic hepatitis B infection.

Mutimer D, Dowling D, Cane P, Ratcliffe D, Tang H, O'Donnell K, Shaw J, Elias E, Pillay D. Mutimer D, et al. Antivir Ther. 2000 Dec;5(4):273-7. Antivir Ther. 2000. PMID: 11142622 Clinical Trial.

10

Acute liver graft failure due to emergence of lamivudine resistant hepatitis B virus: rapid resolution during treatment with adefovir.

Mutimer D, Feraz-Neto BH, Harrison R, O'Donnell K, Shaw J, Cane P, Pillay D. Mutimer D, et al. Gut. 2001 Dec;49(6):860-3. doi: 10.1136/gut.49.6.860. Gut. 2001. PMID: 11709523 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

873 results

Search Page

Filters